ArticleNucleic acids research2026
CellSNVReg: a multidimensional resource for SNV-mediated regulatory perturbations in single-cell and spatial omics.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Single nucleotide variants (SNVs) represent the most prevalent form of genetic variation and can perturb gene regulation, RNA processing, and protein function across multiple molecular layers, ultimately altering cellular functional states and contributing to disease development. Here, we present CellSNVReg (http://bio-bigdata.hrbmu.edu.cn/CellSNVReg/index.jsp), a comprehensive multidimensional resource systematically characterizing regulatory perturbations caused by SNVs at cell-type and spatial resolutions in humans. By integrating 4.6 million cellular profiles from scRNA-seq, spatial transcriptomics, and scATAC-seq across normal, tumor, and other disease tissues, CellSNVReg identifies an average of over 70 000 regulatory perturbations per sample across six dimensions: miRNA-target, transcription factor (TF)-target, enhancer-target, RBP-target, protein-protein interaction, and neoantigen generation, and further characterizes differential expression of perturbed target genes together with associated perturbation networks. For each perturbation, CellSNVReg provides qualitative annotations and quantitative scores to assess SNV perturbation impact, potentially facilitating prioritization of candidate driver SNVs in disease-relevant contexts. To assess downstream functional consequences, the platform links SNV-perturbed targets to alterations in cell functions, states, stemness, metabolism, cell-cell communication, and drug repurposing. In summary, CellSNVReg offers a high-resolution framework for dissecting the functional impact of SNVs across diverse regulatory layers, enabling exploration of the landscape of SNV-mediated regulatory disruptions and their phenotypic consequences in normal and disease contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.